The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice

Psychopharmacology

Volumn 143, Issue 1, 1999, Pages 82-88

  Manzanedo, C ^a   Aguilar, M A ^a   Minarro J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Haloperidol; Mice; Morphine; Motor activity; Sulpiride; U 99194A maleate

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3 (1 PROPYL 3 PIPERIDINYL)BENZONITRILE; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; HALOPERIDOL; MORPHINE; SULPIRIDE; UNCLASSIFIED DRUG; (5,6 DIMETHOXYINDAN 2 YL)DIPROPYLAMINE; (5,6-DIMETHOXYINDAN-2-YL)DIPROPYLAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DRD3 PROTEIN, MOUSE; INDAN DERIVATIVE; NARCOTIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG ANTAGONISM; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC CORTEX; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DRUG EFFECT;

ANIMALS; DOPAMINE ANTAGONISTS; HALOPERIDOL; INDANS; MALE; MICE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SULPIRIDE;

EID: 0032588948     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050922     Document Type: Article

References (45)

1. Aguilar MA, Rodriguez-Arias M, Miñarro J (1995) Efectos del haloperidol y del sulpiride sobre la conducta motora en ratones macho. Psicológica 18:429-439
2. Aguilar MA, Miñarro J, Simón VM (1998) Dose-dependent impairing effects of morphine on avoidance acquisition and performance in male mice. Neurobiol Learn Mem 69:92-105
3. Bassareo V, Tanda G, Petromilli P, Giua C, Di Chiara G (1996) Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat. Psychopharmacologoy 124:293-299
4. Bespalov AY, Zvartau EE (1996) Intraaccumbens administration of NMDA receptor antagonist (+/-)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats. Pharmacol Biochem Behav 55:203-207
5. 3 receptor preferring agonist to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. J Pharmacol Exp Ther 283:794-799
6. Conceicao IM, Frussa-Filhio R (1996) Effects of microgram doses of haloperidol on open-field behavior in mice. Pharmacol Biochem Behav 53:833-838
7. Daly SA, Waddington JL (1993) Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonist. Neuropharmacology 32:509
8. Di Chiara G (1995) Psychobiology of the role of DA in drug abuse and addiction. Psychopharmacology 124:293-299
9. Di Chiara G, Imperato A (1988a) Opposite effects of mu and kappa opiate agonists on dopamine-release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080
10. Di Chiara G, Imperato A (1988b) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278
11. 3 receptor agonist cis-8-OH-PBZI. Eur J Pharmacol 342:153-161
12. Fujiwara H (1992) Comparative studies of sulpiride and classical neuroleptics on indution of catalepsy, locomotor activity, and brain dopamine metabolism in mice. Pharmacol Biochem Behav 41:301-308
13. 1-receptors in morphine-induced hyperlocomotion in mice. Neurosci Lett 169:1-4
14. Gleason SD, Shannon HE (1997) Blockade of phencyclidine induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84
15. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J Pharmacol Exp Ther 275:899-913
16. 3 preferring antagonist (5,6-dimethoxy-2-(dipropylamino) indan). J Med Chem
17. Imperato A, Obinu MC, Casu MA, Mascia MS, Carta G, Gessa GL (1996) Chronic morphine increases hippocampal acetylcholine release: possible relevance in drug dependence. Eur J Pharmacol 302:21-26
18. 3 preferring agonists 7-OH-PIPAT and PD-128, 907 on motor behaviors and place conditioning. Behav Pharmacol 8:65-74
19. Kling-Petersen T, Svensson K (1992) Effects of the preferential dopamine autoreceptor antagonist (+)-AJ76 in the intracranial self-stimulation paradigm. Pharmacol Biochem Behav 43: 495-501
20. Kling-Petersen T, Ljung E, Svensson K (1994) The preferential dopamine autoreceptor antagonist (+)-UH232 antagonizes the positive reinforcing effects of cocaine and d-amphetamine in the ICSS paradigm. Pharmacol Biochem Behav 49:345-351
21. 3 preferring compounds in discrete areas of the rat brain. J Neural Transm [Gen Sect] 102:209-220
22. 3-and autoreceptor preferring antagonist (-)-DS121 on locomotor activity, conditioned place preference and intracranial self-stimulation in the rat. Behav Pharmacol 6:107-115
23. Kuribara H (1995) Caffeine enhances acute stimulant effect of morphine but inhibits morphine sensitization when assessed by ambulation of mice. Progr Neuropsychopharmacol Biol Psychiatry 19:313-321
24. 3 receptor in rat brain using 7-(3H) hydroxy-N, N-di-n-propyl-2-aminote-traline. Proc Natl Acad Sci USA 89:8155-8159
25. Longoni R, Spina L, Di Chiara G (1987) Dopaminergic D-1 receptors: essential role in morpine-induced hypermotility. Psychopharmacology 93:401-402
26. Magnus-Ellenbroek B, Havemann-Reineche U (1993) Morphine induced hyperactivity in rats - a rebound effect? Naunyn-Schmiedeberg's Arch Pharmacol 343:635-642
27. Miyamoto Y, Morita M, Nakamura N, Yamanishi T, Kishiora S, Yamamoto H (1993) Effect of naloxone on the morphine concentration in the central nervous system and plasma in rats. Jpn J Pharmacol 63:235-240
28. Narita M, Suzuki T, Funada M, Misawa M, Nagase H (1993) Involvement of δ-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic system in mice. Psychopharmacology 111:423-426
29. Pearl SM, Hough LB, Boyd DL, Glick SD (1997) Sex difference in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism. Pharmacol Biochem Behav 57:809-815
30. Piercey MF, Lum JT, Hoffmann WE, Carlsson, A, Ljung E, Svensson K (1992) Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ 76 and (+)-UH 232. Brain Res 588:217-222
31. Pontieri FD, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci USA 92: 12304-12308
32. Sautel F, Griffon N, Sokoloff P, Schwartz JC (1995) Nafadotride, a potent preferential dopamine D-sub-3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 275: 1239-1246
33. 1 dopaminergic activity of 7-OH-DPAT. Brain Res 733:41-45
34. 3 dopamine receptor in cellular and organismal function. Psychopharmacology 135:1-16
35. 3) as a target for neuroleptics. Nature 347:146-151
36. Spanagel R, Almeida OFX, Shippenberg TS (1993) Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse 14:243-245
37. Storey VJ, Middlemiss DN, Reavill C (1995) Effect of haloperidol and (-)-sulpiride on dopamine agonist-induced hypoactivity. Neuropharmacology 34:449-455
38. Svensson K, Johanson AM, Magnusson T, Carlsson A (1986) (+)-AJ76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists. Arch Pharmacol 334: 234-245
39. Svensson K, Kling-Petersen T, Waters N, Ekman A, Carlsson A (1991) The preferential dopamine autoreceptor antagonist (+)-AJ76 increases motor activity in habituated rats and antagonizes S-amphetamine-induced hyperactivity. Posters Neurosci 1:75-79
40. 3 and autoreceptor preferring antagonist: effects on locomotor activity in the rat. Soc Neurosci Abstr 19:80
41. 3 receptors. Eur J Pharmacol 263:235-243
42. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J Neural Tansm [Gen Sect] 95:71-74
43. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm [Gen Sect] 94:9-11
44. 3 receptor antogonists in regard to dopamine release, in vivo receptor displacement and behaviour. J Neural Transm [Gen Sect] 98:39-55
45. Yakimowskii AF (1995) Behavior of rats during chronic activation and blockade of the neostriatal opiate system. Neurosci Behav Physiol 25:171-177